To achieve this, we first employed a click chemistry-based approach
A new molecule is emerging: Retatrutide A triple agonist targeting: GLP-1 GIP Glucagon Early clinical data suggests: Up to ~30% weight loss This could represent the next major leap in obesity treatment
Currently, approximately 15% of couples of reproductive age suffer from infertility
For the combos (CJC-1295 + Ipamorelin), the two peptides are already co-formulated in the same vial only one reconstitution is required
Shima Hadidchi, MD , will work closely with you to set realistic expectations, discuss potential benefits and side effects, and develop a comprehensive plan tailored to your individual needs
Results vary significantly based on disease severity and individual response